SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2497)6/24/2009 1:43:25 PM
From: Jibacoa  Respond to of 3722
 
PRXL was up 8.58% earlier, but is up only 7.54% at present.

Volume remains moderate, It is getting close to half its ADV.<g>

The stock had almost a 100% gain from its Apr24 L of $7.82 to its recent Jun18 H of $14.80

bigcharts.marketwatch.com

It seems that if it can close above $15 it could get to test the resistance at $20 (YHOO has a 'target' of $16.22 <g>)

bigcharts.marketwatch.com

On Monday its Perceptive Informatics subsidiary announced that it has launched its 'eClinical Suite', which is expected to provide more effective management and operation of clinical trials.

PRXL has a pretty god institutional following.<g>

finance.yahoo.com

Bernard